Identification of therapeutic targets for glioblastoma by network analysis

20Citations
Citations of this article
66Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Glioblastoma can originate from terminally differentiated astrocytes and neurons, which can dedifferentiate to a stem cell-like state upon transformation. In this study, we confirmed that transformed dedifferentiated astrocytes and neurons acquired a stem/progenitor cell state, although they still retained gene expression memory from their parental cell. Transcriptional network analysis on these cells identified upregulated genes in three main pathways: Wnt signaling, cell cycle and focal adhesion with the gene Spp1, also known as osteopontin (OPN) serving as a key common node connecting these three pathways. Inhibition of OPN blocked the formation of neurospheres, affected the proliferative capacity of transformed neurons and reduced the expression levels of neural stem cell markers. Specific inhibition of OPN in both murine and human glioma tumors prolonged mice survival. We conclude that OPN is an important player in dedifferentiation of cells during tumor formation, hence its inhibition can be a therapeutic target for glioblastoma.

Cite

CITATION STYLE

APA

Friedmann-Morvinski, D., Bhargava, V., Gupta, S., Verma, I. M., & Subramaniam, S. (2016). Identification of therapeutic targets for glioblastoma by network analysis. Oncogene, 35(5), 608–620. https://doi.org/10.1038/onc.2015.119

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free